Cargando…
Increased B4GALT1 expression associates with adverse outcome in patients with non-metastatic clear cell renal cell carcinoma
B4GALT1 is one of seven beta-1, 4-galactosyltransferase (B4GALT) genes, which has distinct functions in various malignances. Here, we evaluate the association of B4GALT1 expression with oncologic outcome in patients with non-metastatic clear cell renal cell carcinoma (ccRCC). A retrospective analysi...
Autores principales: | Xie, Huyang, Zhu, Yu, An, Huimin, Wang, Hongkai, Zhu, Yao, Fu, Hangcheng, Wang, Zewei, Fu, Qiang, Xu, Jiejie, Ye, Dingwei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5078046/ https://www.ncbi.nlm.nih.gov/pubmed/27092876 http://dx.doi.org/10.18632/oncotarget.8737 |
Ejemplares similares
-
High NUCB2 expression level represents an independent negative prognostic factor in Chinese cohorts of non-metastatic clear cell renal cell carcinoma patients
por: Fu, Hangcheng, et al.
Publicado: (2016) -
CCL2/CCR2 axis is associated with postoperative survival and recurrence of patients with non-metastatic clear-cell renal cell carcinoma
por: Wang, Zewei, et al.
Publicado: (2016) -
B4GALT1 expression predicts prognosis and adjuvant chemotherapy benefits in muscle-invasive bladder cancer patients
por: Xie, Huyang, et al.
Publicado: (2018) -
Prognostic value of granulocyte colony-stimulating factor in patients with non-metastatic clear cell renal cell carcinoma
por: Liu, Zheng, et al.
Publicado: (2017) -
A three-molecule score based on Notch pathway predicts poor prognosis in non-metastasis clear cell renal cell carcinoma
por: Liu, Zheng, et al.
Publicado: (2016)